Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.
Narita Y, Matsushima T, Sakamoto Y, Matsuoka H, Tanioka H, Kawakami T, Shoji H, Mizukami T, Izawa N, Nishina T, Yamamoto Y, Mitani S, Nakamura M, Misumi T, Muro K.
Narita Y, et al. Among authors: matsushima t.
ESMO Open. 2023 Dec;8(6):102071. doi: 10.1016/j.esmoop.2023.102071. Epub 2023 Nov 27.
ESMO Open. 2023.
PMID: 38016249
Free PMC article.